Evidence-Based Education in Rheumatology for Advanced Practice Providers
Program Overview
This continuing education activity will highlight evidence-based education in rheumatology for advanced practice providers. The three faculty will review the pathophysiology of rheumatoid arthritis (RA) and psoriatic arthritis (PsA). An analysis of the latest clinical trial data for current and emerging RA and PsA therapeutics will be reviewed. Lastly, the faculty will discuss how to optimize the deployment ...View Course
Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis
Program Overview
This CME/CE program will highlight novel BTK (Bruton’s tyrosine kinase) inhibitors and their effects on adaptive and innate immunity in multiple sclerosis (MS). The expert faculty, led by Dr. Fred D. Lublin, will review BTK inhibitor science as a therapeutic target to reduce neuroinflammation and damage to the CNS in patients with MS. The faculty will analyze the ...View Course
Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events
Program Overview
Heart disease continues to be the leading cause of mortality in Europe. Despite advances in prevention and therapy, each year cardiovascular disease (CVD) causes over 1.8 million deaths in the European Union (EU). CVD accounts for 45% of all deaths in Europe and 37% of all deaths in the EU, is the main cause of death in men ...View Course
Advanced Therapeutic Strategies and Family Planning for Women with Multiple Sclerosis
Program Overview
This program is derived from content presented at the Consortium of Multiple Sclerosis Centers (CMSC) 34th Annual Meeting. This CME/CE activity will highlight advanced therapeutic strategies and family planning best practices for women with multiple sclerosis (MS). The expert faculty, led by Dr. Fred D. Lublin, will analyze the immunopathology, epidemiology, and immune therapeutic targets for MS. Recent ...View Course
A Scientific Update on Therapeutic Agents for the Reversal of Oral Anticoagulants
Program Overview
This CE activity will highlight recent advances in the usage of therapeutic agents for the reversal of oral anticoagulants, particularly in patients with life-threatening bleeds. The expert faculty, Dr. Charles V. Pollack Jr., will review emerging therapies for patients with uncontrolled bleeding as well as discuss the latest data on current therapeutic options for the reversal prior to ...View Course
Novel Treatment Strategies to Improve Outcomes in Patients with Relapsing Remitting Multiple Sclerosis
Program Overview
This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel treatment strategies to improve outcomes in patients with relapsing remitting multiple sclerosis (RRMS). The expert faculty will review the science of relapsing remitting multiple sclerosis, including risk mitigation and the pharmacokinetics of current therapeutic ...
View Course
Novel S1P-Based Therapeutics to Improve Outcomes and Reduce Disability in Patients with Relapsing Multiple Sclerosis
Program Overview
This CME program, derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2020 Course in West Palm Beach, Florida, will highlight novel S1P-based therapeutics to improve outcomes and reduce disability in patients with relapsing multiple sclerosis. The expert faculty will review the recent science of newer S1P-based therapeutics for the treatment of patients with relapsing multiple ...
View Course
A Scientific Overview of the Pharmacological and Non-Pharmacological Treatment Strategies for Parkinson’s Disease
Program Overview
This continuing medical education program will highlight recent advances in the treatment and management of patients with Parkinson’s disease (PD), including data presented at the International Congress of Parkinson’s Disease and Movement Disorders (MDS) 2019 in Nice, France. The three expert faculty will review the pathophysiology of Parkinson’s disease, as well as best practices for early detection and ...View Course
Applying Novel Pharmacotherapies to Improve Outcomes in Patients with Acute Leukemia
Program Overview
This CME/CE activity will highlight recent data for the treatment and management of acute leukemia, including information presented at the American Society of Hematology Annual Meeting in Orlando, Florida. The expert faculty, chaired by Eytan M. Stein, MD, will first discuss the pathophysiology of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), reviewing diagnostic criteria and comorbidities ...View Course
Advanced Strategies to Improve CVD Outcomes in Patients with Chronic Coronary Artery Disease and Peripheral Artery Disease
Program Overview
This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight advanced strategies for improving cardiovascular disease (CVD) outcomes in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD). The expert faculty, chaired by Dr. Christopher P. Cannon, will first provide an introduction and state of ...View Course
